DigiM Solution

DigiM Solution provides advanced microstructure characterization and optimization solutions to pharmaceutical companies. Their proprietary technologies—including high-resolution microscopy, AI-driven image analysis, digital twins of drug products, and in silico dissolution modeling—enable clients to accelerate formulation decisions and predict performance of complex dosage forms. They collaborate with both innovator pharma companies and regulatory agencies such as the FDA to advance understanding of how microstructures impact quality attributes like release profiles. They do not develop their own therapeutics or clinical candidates but instead enable R&D across the industry through contract research services.